Protagenic Therapeutics, Inc.\new (PTIX) Net income 2018–2026
Protagenic Therapeutics, Inc.\new (PTIX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.4MFY2026 · since FY2018: -$2.3M → $1.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.4M | +138.1% |
| FY2025 | -$3.6M | +28.2% |
| FY2024 | -$5.0M | -40.6% |
| FY2023 | -$3.6M | +21.4% |
| FY2022 | -$4.5M | -77.5% |
| FY2021 | -$2.5M | -45.6% |
| FY2020 | -$1.8M | +31.5% |
| FY2019 | -$2.6M | -13.2% |
| FY2018 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice